Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer : Current knowledge and future directionsPAO, William; MILLER, Vincent A.Journal of clinical oncology. 2005, Vol 23, Num 11, pp 2556-2568, issn 0732-183X, 13 p.Article

Optimizing therapy in previously treated non-small cell lung cancerMILLER, Vincent A.Seminars in oncology. 2006, Vol 33, Num 1, issn 0093-7754, S25-S31, SUP1Article

Genomics-based early-phase clinical trials in oncology: Recommendations from the task force on Methodology for the Development of Innovative Cancer TherapiesLIU, Stephen V; MILLER, Vincent A; LOBBEZOO, Marinus W et al.European journal of cancer (1990). 2014, Vol 50, Num 16, pp 2747-2751, issn 0959-8049, 5 p.Article

Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung CancersYU, Helena A; ARCILA, Maria E; REKHTMAN, Natasha et al.Clinical cancer research (Print). 2013, Vol 19, Num 8, pp 2240-2247, issn 1078-0432, 8 p.Article

Next-Generation Sequencing Reveals High Concordance of Recurrent Somatic Alterations Between Primary Tumor and Metastases From Patients With Non-Small-Cell Lung CancerVIGNOT, Stéphane; FRAMPTON, Garrett M; ANDRE, Fabrice et al.Journal of clinical oncology. 2013, Vol 31, Num 17, pp 2167-2172, issn 0732-183X, 6 p.Article

Driver Mutations Determine Survival in Smokers and Never-Smokers With Stage IIIB/IV Lung AdenocarcinomasPAIK, Paul K; JOHNSON, Melissa L; D'ANGELO, Sandra P et al.Cancer. 2012, Vol 118, Num 23, pp 5840-5847, issn 0008-543X, 8 p.Article

Maintained Sensitivity to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer Recurring after Adjuvant Erlotinib or GefitinibOXNARD, Geoffrey R; JANJIGIAN, Yelena Y; MILLER, Vincent A et al.Clinical cancer research (Print). 2011, Vol 17, Num 19, pp 6322-6328, issn 1078-0432, 7 p.Article

New Strategies in Overcoming Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung CancerOXNARD, Geoffrey R; ARCILA, Maria E; CHMIELECKI, Juliann et al.Clinical cancer research (Print). 2011, Vol 17, Num 17, pp 5530-5537, issn 1078-0432, 8 p.Article

Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancerMILTON, Daniel T; RIELY, Gregory J; MILLER, Vincent A et al.Cancer. 2007, Vol 110, Num 3, pp 599-605, issn 0008-543X, 7 p.Article

Molecular on/off switchMILTON, Daniel T; RIELY, Gregory J; PAO, William et al.Journal of clinical oncology. 2006, Vol 24, Num 30, pp 4940-4942, issn 0732-183X, 3 p.Article

Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinibEBERHARD, David A; JOHNSON, Bruce E; KLEIN, Pam et al.Journal of clinical oncology. 2005, Vol 23, Num 25, pp 5900-5909, issn 0732-183X, 10 p.Article

Advances in cytotoxic chemotherapy for the treatment of metastatic or recurrent non-small cell lung cancerMILTON, Daniel T; MILLER, Vincent A.Seminars in oncology. 2005, Vol 32, Num 3, pp 299-314, issn 0093-7754, 16 p.Article

Using patients as their own controls for cost evaluation of phase I clinical trialsSHERMAN, Eric J; RUBIN, David M; VENKATRAMAN, Ennapadam et al.Journal of clinical oncology. 2004, Vol 22, Num 7, pp 1308-1314, issn 0732-183X, 7 p.Article

Thoracic radiotherapy for limited-stage small cell lung cancer: Issues of timing, volumes, dose, and fractionationERRIDGE, Sara C; MURRAY, Nevin.Seminars in oncology. 2003, Vol 30, Num 1, pp 26-37, issn 0093-7754, 12 p.Article

Lung cancer: The oncologist's role in smoking cessationAHUJA, Rohit; WEIBEL, Sandra B; LEONE, Frank T et al.Seminars in oncology. 2003, Vol 30, Num 1, pp 94-103, issn 0093-7754, 10 p.Article

Co-administration of probenecid, an inhibitor of a cMOAT/MRP-like plasma membrane ATPase, greatly enhanced the efficacy of a new 10-deazaaminopterin against human solid tumors in vivoSIROTNAK, F. M; WENDEL, H. Guido; BORNMANN, William G. B et al.Clinical cancer research. 2000, Vol 6, Num 9, pp 3705-3712, issn 1078-0432Article

Disease Flare after Tyrosine Kinase Inhibitor Discontinuation in Patients with EGFR-Mutant Lung Cancer and Acquired Resistance to Erlotinib or Gefitinib: Implications for Clinical Trial DesignCHAFT, Jamie E; OXNARD, Geoffrey R; SIMA, Camelia S et al.Clinical cancer research (Print). 2011, Vol 17, Num 19, pp 6298-6303, issn 1078-0432, 6 p.Article

Incidence of EGFR Exon 19 Deletions and L858R in Tumor Specimens From Men and Cigarette Smokers With Lung AdenocarcinomasD'ANGELO, Sandra P; CATHERINE PIETANZA, M; JOHNSON, Melissa L et al.Journal of clinical oncology. 2011, Vol 29, Num 15, pp 2066-2070, issn 0732-183X, 5 p.Article

Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non―Small-Cell Lung CancerJACKMAN, David; PAO, William; RIELY, Gregory J et al.Journal of clinical oncology. 2010, Vol 28, Num 2, pp 357-360, issn 0732-183X, 4 p.Article

A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancerMILTON, Daniel T; AZZOLI, Christopher G; MILLER, Vincent A et al.Cancer. 2006, Vol 107, Num 5, pp 1034-1041, issn 0008-543X, 8 p.Article

Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomasPHAM, Duykhanh; KRIS, Mark G; WILSON, Richard K et al.Journal of clinical oncology. 2006, Vol 24, Num 11, pp 1700-1704, issn 0732-183X, 5 p.Article

Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein : A phase II clinical trialKRUG, Lee M; CRAPANZANO, John P; HEELAN, Robert T et al.Cancer. 2005, Vol 103, Num 10, pp 2128-2131, issn 0008-543X, 4 p.Article

Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinomaKRUG, Lee M; MILLER, Vincent A; SHEEHAN, Christine et al.Cancer. 2005, Vol 104, Num 10, pp 2149-2155, issn 0008-543X, 7 p.Article

Chemotherapy for small cell lung cancerSANDLER, Alan B.Seminars in oncology. 2003, Vol 30, Num 1, pp 9-25, issn 0093-7754, 17 p.Article

Molecular and cellular biology of small cell lung cancerSATTLER, Martin; SALGIA, Ravi.Seminars in oncology. 2003, Vol 30, Num 1, pp 57-71, issn 0093-7754, 15 p.Article